SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-14-017648
Filing Date
2014-09-30
Accepted
2014-09-30 16:35:41
Documents
14
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K bota20140630_10k.htm 10-K 2179902
2 EXHIBIT 21.1 ex21-1.htm EX-21 3458
3 EXHIBIT 23.1 ex23-1.htm EX-23 3203
4 EXHIBIT 23.1A ex23-1a.htm EX-23 3215
5 EXHIBIT 31.1 ex31-1.htm EX-31 11167
6 EXHIBIT 32.1 ex32-1.htm EX-32 4932
13 chart01.jpg GRAPHIC 56581
14 bota20140630_10kimg001.gif GRAPHIC 63310
  Complete submission text file 0001437749-14-017648.txt   10233547

Data Files

Seq Description Document Type Size
7 EXHIBIT 101.INS bota-20140630.xml EX-101.INS 1631440
8 EXHIBIT 101.SCH bota-20140630.xsd EX-101.SCH 62546
9 EXHIBIT 101.CAL bota-20140630_cal.xml EX-101.CAL 43414
10 EXHIBIT 101.DEF bota-20140630_def.xml EX-101.DEF 289260
11 EXHIBIT 101.LAB bota-20140630_lab.xml EX-101.LAB 413346
12 EXHIBIT 101.PRE bota-20140630_pre.xml EX-101.PRE 295517
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Biota Pharmaceuticals, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-35285 | Film No.: 141130119
SIC: 2836 Biological Products, (No Diagnostic Substances)